Using a Cold Atmospheric Plasma Device to Treat Skin Disorders
NCT ID: NCT02759900
Last Updated: 2022-04-12
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
100 participants
INTERVENTIONAL
2016-01-31
2025-01-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Rosacea Treatment Using Non-thermal (cold) Atmospheric Plasma Device
NCT05592548
Cold Atmospheric Plasma for Moderate-to-severe Acne Vulgaris Study
NCT07056673
Safety and Preliminary Efficacy of Combination Therapy for the Treatment of Acne Vulgaris
NCT02431494
NdYag Laser for Acne Keloidalis Nuchae
NCT00757315
Safety Study of Plasma Treatment System to Treat Back Acne
NCT01662349
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Non-thermal atmospheric plasma treatment
Device treatment
Non-thermal, atmospheric plasma to treat skin lesions and acne
Non-thermal, atmospheric plasma treatment of affected area or lesions using a nanosecond dielectric barrier discharge plasma device
Indirect non-thermal atmospheric plasma treatment
A compound of non-thermal atmospheric plasma and medium is used to treat the target by direct application or by on-site generation of the compound
Indirect non-thermal, atmospheric plasma to treat hair loss and acne
A compound of non-thermal, atmospheric plasma and medium is delivered to or generated at the target area. Plasma is generated using either microsecond dielectric barrier discharge plasma device or PiezoBrush (a helium jet plasma). The medium is an aqueous alcohol solution
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Non-thermal, atmospheric plasma to treat skin lesions and acne
Non-thermal, atmospheric plasma treatment of affected area or lesions using a nanosecond dielectric barrier discharge plasma device
Indirect non-thermal, atmospheric plasma to treat hair loss and acne
A compound of non-thermal, atmospheric plasma and medium is delivered to or generated at the target area. Plasma is generated using either microsecond dielectric barrier discharge plasma device or PiezoBrush (a helium jet plasma). The medium is an aqueous alcohol solution
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* ability to complete study protocol
Exclusion Criteria
4 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
The Skin Center Dermatology Group
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
The Skin Center Dermatology Group
New City, New York, United States
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Friedman PC, Fridman G, Fridman A. Cold atmospheric pressure plasma clears molluscum contagiosum. Exp Dermatol. 2023 Apr;32(4):562-563. doi: 10.1111/exd.14695. Epub 2022 Nov 3. No abstract available.
Malik S, Gill M, Fridman G, Fridman A, Friedman PC. Cold atmospheric plasma reduces demodex count on the face comparably to topical ivermectin, as measured by reflectance confocal microscopy. Exp Dermatol. 2022 Sep;31(9):1352-1354. doi: 10.1111/exd.14584. Epub 2022 May 11. No abstract available.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
20130084
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.